Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Allergy, 2023

Mechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80

Ogulur I., Yazici D., Pat Y. et al.

International Immunopharmacology, 2023

Cytokine patterns in the blister fluid and plasma of patients with fracture blisters

Li Y., Long Y., Chen X. et al.

Journal of Allergy and Clinical Immunology, 2023

Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics

Al-Janabi A., Martin P., Khan A. et al.

Cytokine, 2023

Lower levels of Th1 and Th2 cytokines in cerebrospinal fluid (CSF) at the time of initial CSF shunt placement in children are associated with subsequent shunt revision surgeries

Simon T., Sedano S., Rosenberg-Hasson Y. et al.

European Journal of Immunology, 2023

Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals

Bi W., Kraft A., Engelskircher S. et al.

Clinical and Molecular Allergy, 2023

Systemic inflammatory proteins in offspring following maternal probiotic supplementation for atopic dermatitis prevention

Zakiudin D., Rø A., Videm V. et al.

JAMA Network Open, 2023

Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk

Sood T., Perrot N., Chong M. et al.

Hematological Oncology, 2023

Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study

Hamadani M., Coleman M., Boccia R. et al.

eBioMedicine, 2023

Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination

Duran-Castells C., Prats A., Oriol-Tordera B. et al.

Journal of Circulating Biomarkers, 2023

Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™

Berggrund M., Ekman D., Gustavsson I. et al.

Translational Research, 2023

Plasma protein signatures reflect systemic immunity and allograft function in kidney transplantation

Buscher K., Rixen R., Schütz P. et al.

Pulmonary Circulation, 2023

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension

Arvidsson M., Ahmed A., Säleby J. et al.

Frontiers in Immunology, 2023

Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM

Wong S., Hamidi H., Costa L. et al.

Journal of the American Heart Association, 2023

Novel Biomarkers of Necrotizing Enterocolitis in Neonates Undergoing Congenital Heart Disease Surgery: A Pilot Cohort Study

Ali E., Syed A., Khailova L. et al.

Diabetes, Obesity and Metabolism, 2023

Hypoglycaemia induces a sustained pro‐inflammatory response in people with type 1 diabetes and healthy controls

Verhulst C., van Heck J., Fabricius T. et al.

European Journal of Neurology, 2023

Paraneoplastic or not? Sirtuin 2 in anti‐N‐methyl‐d‐aspartate receptor encephalitis

Stevens‐Jones O., Mojzisova H., Elisak M. et al.

Cardiovascular Research, 2023

A machine learning based approach to identify carotid subclinical atherosclerosis endotypes

Chen Q., Bergman O., Ziegler L. et al.

Journal of Dermatological Science, 2023

Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasis

Deng J., Leijten E., Zhu Y. et al.

Neurological Research and Practice, 2023

Novel inflammatory biomarkers associated with stroke severity: results from a cross-sectional stroke cohort study

Braadt L., Naumann M., Freuer D. et al.

Science Translational Medicine, 2023

Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma

Schmassmann P., Roux J., Buck A. et al.

4586 publications